openPR Logo
Press release

Parkinson’s Disease Treatment Market Size, Share, Analysis and Forecast - 2025

07-22-2020 02:16 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Parkinson’s Disease Treatment Market

Parkinson’s Disease Treatment Market

Global Parkinson’s Disease Treatment Market Size, Share & Trends Analysis Report by Type ((Drugs (Dopamine Receptor Agonists, MAO-Inhibitors, Carbidopa-Levodopa, Catechol O-methyltransferase (COMT) Inhibitors, Anticholinergics, and Others) and Surgical Procedures (Deep Brain Stimulation, Vagus Nerve Stimulation, and Others), Fo The global Parkinson’s disease treatment market is expected to grow at a CAGR of over 6% during the forecast period. The primary factors that drive the growth of the global Parkinson’s disease treatment industry include the increased incidences of Parkinson’s diseases across the globe. The increased prevalence of neurological disorders such as Parkinson’s and other diseases have encouraged the players to perform R&D activities for the development of novel and advanced treatment options. Also, various studies have been done to develop the total cure and increased effectiveness of the treatment of the disease.

Get Sample Copy of Parkinson’s Disease Treatment Market at: https://www.omrglobal.com/request-sample/parkinsons-disease-treatment-market

Some of the prominent players functioning in the global Parkinson’s disease treatment market Medtronic Plc, AbbVie Inc., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Boston Scientific Corp., Cipla Inc., Mylan NV, Novartis International AG, Eli Lilly& Co., Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others.

In August 2019, a study was conducted by Johns Hopkins Medicine associated with Parkinson’s disease via deep brain stimulator (DBS) treatment. The DBS through electrical impulses jump starts the nerve cells that produce the dopamine to lessens muscle rigidity and tremors that are the basic symptoms of Parkinson’s disease. The research was performed on seven people to study the change in dopamine levels in the brain.

The researchers performed PET (Positron Emission Tomography) scan on a patient with Parkinson’s disease taking dopamine increasing medications (levodopa), using a tracer for Vesicular Monoamine Transporter 2 (VMAT2). The scans showed that, as the dopamine levels in the brain increase with levodopa, VMAT2 levels decrease, and vice versa. The researchers found that, after DBS, patients having Parkinson’s disease had fewer tremors and less rigidity, and patients showed improvement in cognitive abilities and mood, with depression scores dropping by 40%.

For More Information, get A full report of Parkinson’s Disease Treatment Market is available at: https://www.omrglobal.com/industry-reports/parkinsons-disease-treatment-market

Further, the global Parkinson’s disease treatment market has significant players operating in the industry and providing medications and surgical procedures globally. These players are significantly contributing to expanding the global Parkinson’s disease treatment market size during the forecast period.

Current Market Trends Covered in the market report:

Increased spending on the healthcare R&D activities by the government and private organizations are positively affecting the Parkinson’s disease treatment market growth
Deep Brain Stimulators (DBS) segment will account for significant growth in the market
The novel innovations and product enhancements will be the key strategy adopted by the players

The Asia-Pacific region will register a significant growth rate in Parkinson’s Disease Treatment market globally

Global Parkinson’s Disease Treatment Market – Segmentation

By Type

• Drugs
• Surgical Procedures

Global Parkinson’s Disease Treatment Market – Segmentation by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/parkinsons-disease-treatment-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson’s Disease Treatment Market Size, Share, Analysis and Forecast - 2025 here

News-ID: 2094848 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082 The report provides a comprehensive analysis of company profiles listed below: - Teva - Roche - Prothena - Acorda
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Parkinson’s Disease Treatment with respect
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial